HR
Q3 2026 EPS Estimate
$-0.01
Jul 30, 2026 · Reports after close
Revenue Estimate
$275M
FY2027E EPS$0.02
FY2028E EPS$0.09

Analyst Sentiment

Wall St. Consensus
Hold
27 analysts·High coverage
55
Score
7 Buy (26%)18 Hold (67%)2 Sell (7%)
Rating Breakdown
Strong Buy
00%
Buy
726%
Hold
1867%
Sell
27%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$20.00
-0.8%
Consensus
$22.00
+9.1%
Bull
$24.00
+19.0%
12-Month Target Range27 analysts
$20.00$22.00$24.00
Current $20.17Consensus
Current Price
$20.17
Upside to Consensus
$1.83

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+3.58%
EPS
FY2028
Rev+3.95%
EPS+270.31%
FY2029
Rev-2.13%
EPS+19.03%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2026EFY2027EFY2028EFY2029E
Revenue Avg$1.11B$1.15B$1.20B$1.17B
Low$1.09B$1.13B$1.18B$1.15B
High$1.14B$1.18B$1.21B$1.20B
EBITDA Avg$549M$568M$591M$578M
Low$539M$558M$582M$568M
High$562M$582M$599M$592M
EBIT Avg$11M$11M$12M$12M
Low$11M$11M$12M$11M
High$11M$12M$12M$12M
Net Income Avg$-7M$9M$21M$38M
Low$-8M$9M$18M$38M
High$-7M$9M$47M$40M
EPS Avg$-0.02$0.02$0.09$0.11
Low$-0.02$0.02$0.05$0.11
High$-0.02$0.03$0.13$0.11
Analysts (Rev / EPS)5 / 34 / 23 / 22 / 1
Quarterly
MetricQ3 2026Q4 2026Q1 2027Q2 2027Q3 2027Q4 2027Q1 2028Q2 2028
Revenue Avg$276M$279M$279M$282M$285M$288M$290M$293M
Low$272M$274M$275M$277M$280M$283M$285M$288M
High$280M$282M$283M$286M$289M$291M$294M$297M
EBITDA Avg$136M$138M$138M$139M$141M$142M$143M$145M
Low$134M$135M$136M$137M$138M$140M$141M$142M
High$138M$139M$140M$141M$142M$144M$145M$146M
EBIT Avg$3M$3M$3M$3M$3M$3M$3M$3M
Low$3M$3M$3M$3M$3M$3M$3M$3M
High$3M$3M$3M$3M$3M$3M$3M$3M
Net Income Avg$-2M$959,975$5M$7M$10M$12M$14M$17M
Low$-2M$939,434$5M$7M$9M$12M$14M$17M
High$-2M$975,866$5M$7M$10M$12M$15M$18M
EPS Avg$-0.00$0.00$0.01$0.02$0.03$0.04$0.04$0.05
Low$-0.01$0.00$0.01$0.02$0.03$0.03$0.04$0.05
High$-0.00$0.00$0.01$0.02$0.03$0.04$0.04$0.05
Analysts (Rev / EPS)2 / 31 / 11 / 11 / 11 / 11 / 11 / 11 / 1

Earnings Surprises

Recent Analyst Actions

Jun 16, 2026Raymond James
Healthcare Realty Trust resumed with an Outperform at Raymond James
Target:$24.00
+17.1%from $20.50
Jun 12, 2026BTIG
Healthcare Realty Trust price target raised to $22 from $20 at BTIG
Target:$22.00
+7.3%from $20.50
May 14, 2026RBC Capital
Healthcare Realty Trust price target raised to $21 from $19 at RBC Capital
Target:$21.00
+3.2%from $20.34
May 13, 2026UBS
Healthcare Realty Trust price target raised to $20 from $18 at UBS
Target:$20.00
-0.6%from $20.13
May 8, 2026Scotiabank
Healthcare Realty Trust price target raised to $22 from $20 at Scotiabank
Target:$22.00
+9.6%from $20.07
May 4, 2026Cantor Fitzgerald
Healthcare Realty Trust price target raised to $22 from $21 at Cantor Fitzgerald
Target:$22.00
+13.4%from $19.41
Apr 20, 2026UBS
Healthcare Realty Trust initiated with a Neutral at UBS
Target:$18.00
-3.4%from $18.63
Feb 17, 2026Cantor Fitzgerald
Healthcare Realty Trust price target raised to $21 from $19 at Cantor Fitzgerald
Target:$21.00
+16.9%from $17.96
Nov 25, 2025Wells Fargo
Healthcare Realty Trust price target raised to $19 from $18 at Wells Fargo
Target:$19.00
+5.3%from $18.05
Oct 20, 2025Wells Fargo
Healthcare Realty upgraded to Equal Weight from Underweight at Wells Fargo
Target:$18.00
-3.2%from $18.60
Oct 8, 2025RBC Capital
Healthcare Realty Trust initiated with a Sector Perform at RBC Capital
Target:$19.00
+5.8%from $17.96
Oct 1, 2025Cantor Fitzgerald
Healthcare Realty Trust initiated with an Overweight at Cantor Fitzgerald
Target:$23.00
+27.6%from $18.03
Aug 7, 2024Scotiabank
Healthcare Realty Trust price target raised to $18 from $17 at Scotiabank
Target:$18.00
-0.2%from $18.04
Jul 30, 2024Wells Fargo
Wells Fargo Downgrades Healthcare Realty Trust (HR) to Underweight
Target:$16.00
-10.7%from $17.91
May 16, 2024Scotiabank
Healthcare Realty Trust price target raised to $16 from $15 at Scotiabank
Target:$16.00
-1.9%from $16.32
Apr 10, 2024Wells Fargo
Healthcare Realty Trust (HR) PT Lowered to $15 at Wells Fargo
Target:$15.00
+2.8%from $14.59
Dec 14, 2022Citigroup
Citigroup Downgrades Healthcare Realty Trust to Neutral, Lowers Price Target to $20
Target:$20.00
+1.3%from $19.74
Dec 2, 2022J.P. Morgan
JP Morgan Maintains Neutral on Healthcare Realty Trust, Lowers Price Target to $22
Target:$22.00
+9.4%from $20.11
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.